Buyer Name: Gloucestershire Hospitals NHS Foundation Trust
Buyer Address: Alexandra House, Cheltenham General Hospital, Sandford Road, Gloucester, UKK1, GL53 7AN, United Kingdom
Contact Name: Kelly Attwood
Contact Email: kattwood@nhs.net
Buyer Name: Gloucestershire Hospitals NHS Foundation Trust
Buyer Address: Alexandra House, Cheltenham General Hospital, Sandford Road, Gloucester, UKK1, GL53 7AN, United Kingdom
Contact Name: Kelly Attwood
Contact Email: kattwood@nhs.net
Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.
No linked documents found for this notice.
Lot Description: This contract is to commission Exact Science to provide Oncotype DX Breast Recurrence Score which is a genomic assay that provides a personalised insight into an individual patients breast cancer biology. <br/>This contract has been awarded under Direct Award A <br/>The lifetime value of this contract is £214,650 <br/>The contract is in place from 1st July 2025 until 30th June 2026
Lot 1 Status: cancelled
Lot 1 Has Options: No
{
"awards": [
{
"id": "009502-2026-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-116543",
"name": "Exact Sciences UK, Ltd."
}
]
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"buyer": {
"id": "GB-FTS-76446",
"name": "Gloucestershire Hospitals NHS Foundation Trust"
},
"contracts": [
{
"awardID": "009502-2026-1",
"dateSigned": "2026-02-03T00:00:00Z",
"id": "009502-2026-1",
"status": "active",
"value": {
"amount": 214650.0,
"currency": "GBP"
}
}
],
"date": "2026-02-03T14:27:47Z",
"description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provision of the Public Contracts Regulations 2015 do not apply to this award. \u003cbr/\u003eDecision Makers involved were Siobhan Taylor, Lead Clinical Scientist, Kelly Attwood, Contracts Manager \u003cbr/\u003eThere were no conflicts of interests declared.",
"id": "009502-2026",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-061579",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Gloucester",
"postalCode": "GL53 7AN",
"region": "UKK1",
"streetAddress": "Alexandra House, Cheltenham General Hospital, Sandford Road"
},
"contactPoint": {
"email": "kattwood@nhs.net",
"name": "Kelly Attwood"
},
"details": {
"buyerProfile": "https://www.gloshospitals.nhs.uk/",
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "https://www.gloshospitals.nhs.uk/"
},
"id": "GB-FTS-76446",
"identifier": {
"legalName": "Gloucestershire Hospitals NHS Foundation Trust"
},
"name": "Gloucestershire Hospitals NHS Foundation Trust",
"roles": [
"buyer",
"reviewBody"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SE1 7LY",
"region": "UKI3",
"streetAddress": "Scott House - The Concourse Waterloo Station London"
},
"contactPoint": {
"email": "europeansupport@exactsciences.com",
"faxNumber": "+44 2039983233",
"telephone": "+44 2039983233"
},
"details": {
"scale": "sme",
"url": "http://www.exactsciences.com/uk"
},
"id": "GB-FTS-116543",
"identifier": {
"id": "07484560",
"legalName": "Exact Sciences UK, Ltd."
},
"name": "Exact Sciences UK, Ltd.",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Pathology services",
"id": "85111800",
"scheme": "CPV"
},
"coveredBy": [
"GPA"
],
"description": "Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.",
"id": "ocds-h6vhtk-061579",
"items": [
{
"deliveryAddresses": [
{
"region": "UKK13"
}
],
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"description": "This contract is to commission Exact Science to provide Oncotype DX Breast Recurrence Score which is a genomic assay that provides a personalised insight into an individual patients breast cancer biology. \u003cbr/\u003eThis contract has been awarded under Direct Award A \u003cbr/\u003eThe lifetime value of this contract is \u00a3214,650 \u003cbr/\u003eThe contract is in place from 1st July 2025 until 30th June 2026",
"hasOptions": false,
"id": "1",
"status": "cancelled"
}
],
"mainProcurementCategory": "services",
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "Direct Award A due to there being only one provider of this service",
"procurementMethodRationaleClassifications": [
{
"description": "The procurement falls outside the scope of application of the directive",
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"status": "complete",
"title": "Send Away Test for Oncotype DX Breast Recurrence Score"
}
}